Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
Go back to Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer| CARA THERAPEUTICS (NASDAQ: CARA) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $17.69 | |||
| Open | $5.32 | 52 Week Low | $4.26 | |||
| Day High | $5.32 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.42 | |||
| Volume | 1,036 | |||||
| (NASDAQ: IOVA) | Delayed: 4.76 +0.02 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.74 | 52 Week High | $ | |||
| Open | $4.76 | 52 Week Low | $ | |||
| Day High | $4.76 | P/E | N/A | |||
| Day Low | $4.76 | EPS | $ | |||
| Volume | 7,422 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 41.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.18 | 52 Week High | $4.38 | |||
| Open | $41.18 | 52 Week Low | $1.88 | |||
| Day High | $41.18 | P/E | N/A | |||
| Day Low | $41.18 | EPS | $-1.12 | |||
| Volume | 2 | |||||
